The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Labour's demands for tougher safeguards on shale gas extraction were accepted by MPs but attempts to introduce a moratorium were defeated.
League One side will face either Sunderland or Fulham after knocking out Premier League leaders Chelsea.
Actress will play Belle in a live-action remake of Disney's animated film Beauty and the Beast.